305 related articles for article (PubMed ID: 24867426)
1. Rapidly dissolvable microneedle patches for transdermal delivery of exenatide.
Zhu Z; Luo H; Lu W; Luan H; Wu Y; Luo J; Wang Y; Pi J; Lim CY; Wang H
Pharm Res; 2014 Dec; 31(12):3348-60. PubMed ID: 24867426
[TBL] [Abstract][Full Text] [Related]
2. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation.
Chen C; Zheng H; Xu J; Shi X; Li F; Wang X
Daru; 2017 Sep; 25(1):20. PubMed ID: 28870261
[TBL] [Abstract][Full Text] [Related]
4. Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes.
Hu M; Zhang Y; Xiang N; Zhong Y; Gong T; Zhang ZR; Fu Y
Pharm Res; 2016 Jun; 33(6):1318-26. PubMed ID: 26857900
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of a once-weekly formulation of an antidiabetic peptide drug exenatide in an injectable thermogel.
Yu L; Li K; Liu X; Chen C; Bao Y; Ci T; Chen Q; Ding J
J Pharm Sci; 2013 Nov; 102(11):4140-9. PubMed ID: 24114868
[TBL] [Abstract][Full Text] [Related]
6. Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by enterovirus 71.
Zhu Z; Ye X; Ku Z; Liu Q; Shen C; Luo H; Luan H; Zhang C; Tian S; Lim C; Huang Z; Wang H
J Control Release; 2016 Dec; 243():291-302. PubMed ID: 27793685
[TBL] [Abstract][Full Text] [Related]
7. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.
Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917
[TBL] [Abstract][Full Text] [Related]
8. Thermal stability of exenatide encapsulated in stratified dissolving microneedles during storage.
Liu H; Wang B; Xing M; Meng F; Zhang S; Yang G; Cheng A; Yan C; Xu B; Gao Y
Int J Pharm; 2023 Apr; 636():122863. PubMed ID: 36934885
[TBL] [Abstract][Full Text] [Related]
9. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor.
Zhao X; Li X; Zhang P; Du J; Wang Y
J Control Release; 2018 Sep; 286():201-209. PubMed ID: 30056119
[TBL] [Abstract][Full Text] [Related]
10. Rapidly separating microneedles for transdermal drug delivery.
Zhu DD; Wang QL; Liu XB; Guo XD
Acta Biomater; 2016 Sep; 41():312-9. PubMed ID: 27265152
[TBL] [Abstract][Full Text] [Related]
11. Insulin delivery systems combined with microneedle technology.
Jin X; Zhu DD; Chen BZ; Ashfaq M; Guo XD
Adv Drug Deliv Rev; 2018 Mar; 127():119-137. PubMed ID: 29604374
[TBL] [Abstract][Full Text] [Related]
12. The effects of molecular weight of hyaluronic acid on transdermal delivery efficiencies of dissolving microneedles.
Chi Y; Huang Y; Kang Y; Dai G; Liu Z; Xu K; Zhong W
Eur J Pharm Sci; 2022 Jan; 168():106075. PubMed ID: 34813921
[TBL] [Abstract][Full Text] [Related]
13. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.
Ling MH; Chen MC
Acta Biomater; 2013 Nov; 9(11):8952-61. PubMed ID: 23816646
[TBL] [Abstract][Full Text] [Related]
14. Pullulan microneedle patches for the efficient transdermal administration of insulin envisioning diabetes treatment.
Fonseca DFS; Costa PC; Almeida IF; Dias-Pereira P; Correia-Sá I; Bastos V; Oliveira H; Duarte-Araújo M; Morato M; Vilela C; Silvestre AJD; Freire CSR
Carbohydr Polym; 2020 Aug; 241():116314. PubMed ID: 32507191
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of AC3174, a peptide analog of exendin-4.
Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
[TBL] [Abstract][Full Text] [Related]
16. Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin.
Chen MC; Ling MH; Kusuma SJ
Acta Biomater; 2015 Sep; 24():106-16. PubMed ID: 26102333
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic Acid-Based Dissolving Microneedle Patch Loaded with Methotrexate for Improved Treatment of Psoriasis.
Du H; Liu P; Zhu J; Lan J; Li Y; Zhang L; Zhu J; Tao J
ACS Appl Mater Interfaces; 2019 Nov; 11(46):43588-43598. PubMed ID: 31651148
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo assessment of polymer microneedles for controlled transdermal drug delivery.
Chen BZ; Ashfaq M; Zhang XP; Zhang JN; Guo XD
J Drug Target; 2018 Sep; 26(8):720-729. PubMed ID: 29301433
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of composite microneedles integrated with insulin-loaded CaCO
Liu D; Yu B; Jiang G; Yu W; Zhang Y; Xu B
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():180-188. PubMed ID: 29853081
[TBL] [Abstract][Full Text] [Related]
20. Two-Layer Sustained-Release Microneedles Encapsulating Exenatide for Type 2 Diabetes Treatment.
Liu H; Zhang S; Zhou Z; Xing M; Gao Y
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
